Poland· PL-100257285
Reparil
A aescin product containing escinum, registered in Poland by Delfarma Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Escinum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C05CA07
- ATC class
- Aescin
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909997196794
- gtin05909997196800
- gtin05909997196817
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aescin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaREPARIL DRAGÉESCooper Consumer Health B.V., Diemen
- BelgiumReparil 20 mgImpexeco
- GermanyReparilCooper Consumer Health Deutschland Gmbh
- SpainFLEBOSTASIN RETARD 50 mg CÁPSULAS DURAS DE LIBERACIÓN PROLONGADAGlenwood Gmbh Pharmazeutische Erzeugnisse
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Reparil, Venostasin
- Belgium · Reparil
- Bulgaria · Репарил
- Czechia · Aescin Teva, Reparil Dragées
- Germany · Reparil-Dragees, Reparil-Dragees Zur Anwendung Bei Erwachsenen Und Kindern Ab 7 Jahren
- Italy · Edevexin, Reparilexin
- Slovakia · Aescin, Aescin Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a6c9400-160e-412b-b5fb-f32bb242e145 GET /v1/drugs/9a6c9400-160e-412b-b5fb-f32bb242e145?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki dojelitowe",
"source": "urpl",
"strength": "20 mg",
"packaging": "05909997196794 ¦ OTC ¦ 46826\n20 tabl.\n05909997196800 ¦ OTC ¦ 47086\n40 tabl.\n05909997196817 ¦ OTC ¦ 48241\n100 tabl.",
"substance": null,
"common_name": "Escinum",
"pl_product_id": "100257285",
"pozwolenie_nr": "120/11",
"auth_procedure": "IR",
"authorisation_validity": "2031-04-27"
}See everything about aescin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.